Literature DB >> 18359977

Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.

Yaguang Xi1, Adam Riker, Lalita Shevde-Samant, Rajeev Samant, Christopher Morris, Elaine Gavin, Oystein Fodstad, Jingfang Ju.   

Abstract

Various in vitro and in vivo experimental models have been used for the discovery of genes and pathways involved in melanoma and other types of cancer. However, in many cases, the results from various tumor models failed to be validated successfully in clinical studies. Limited information is available on how closely these models reflect the in vivo physiological conditions. In this study, a comprehensive genomics approach was used to systematically compare the expression patterns of snap frozen samples obtained from patients with primary melanoma, lymph node metastasis, and distant metastases, and compare these patterns to those of their corresponding cell lines and tumor xenografts in nude mice. The GE Healthcare 20k human genome array was used and the expression data was normalized and analyzed using GeneSpring 7.2 software. Based on the expression analysis, the correlation rate between the snap frozen primary patient samples vs. derived cell lines was 66%, with 1687 differentially expressed genes. The correlation rate between the snap frozen primary patient samples and the tumor xenografts was 75%, with 1,374 differentially expressed genes, and the correlation rate comparing tumor xenografts to derived cell lines ranged between 58% and 84%. These results demonstrated significant gene expression differences between tumor materials with different in vitro and in vivo growth microenvironments. Such studies can help us to distinguish between genes up- or down-regulated as a result of the microenvironment and those stably expressed independently of the tumor milieu. With the extensive use of cell lines and xenografts in cancer research, the information obtained using our approach may help to better interpret results generated from different tumor models by understanding common differences, as well as similarities at the gene expression level, information that may have important practical and biological implications.

Entities:  

Mesh:

Year:  2008        PMID: 18359977      PMCID: PMC3226839     

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  29 in total

1.  Chemosensitivity prediction by transcriptional profiling.

Authors:  J E Staunton; D K Slonim; H A Coller; P Tamayo; M J Angelo; J Park; U Scherf; J K Lee; W O Reinhold; J N Weinstein; J P Mesirov; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  A genome-based strategy uncovers frequent BRAF mutations in melanoma.

Authors:  Pamela M Pollock; Paul S Meltzer
Journal:  Cancer Cell       Date:  2002-07       Impact factor: 31.743

3.  Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.

Authors:  Lalita A Shevde; Rajeev S Samant; Steven F Goldberg; Tabo Sikaneta; Alessandro Alessandrini; Henry J Donahue; David T Mauger; Danny R Welch
Journal:  Exp Cell Res       Date:  2002-02-15       Impact factor: 3.905

4.  Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells.

Authors:  Jane H C Lin; Takahiro Takano; Maria Luisa Cotrina; Gregory Arcuino; Jian Kang; Shujun Liu; Qun Gao; Li Jiang; Fanshu Li; Hella Lichtenberg-Frate; Sandra Haubrich; Klaus Willecke; Steven A Goldman; Maiken Nedergaard
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

5.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

Review 6.  Dynamics of cell interactions and communications during melanoma development.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Crit Rev Oral Biol Med       Date:  2002

7.  Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.

Authors:  Karin Milde-Langosch; Stanislava Janke; Ines Wagner; Christine Schröder; Thomas Streichert; Ana-Maria Bamberger; Fritz Jänicke; Thomas Löning
Journal:  Breast Cancer Res Treat       Date:  2007-03-28       Impact factor: 4.872

8.  Increased invasive capacity of connexin43-overexpressing malignant glioma cells.

Authors:  Wei Zhang; Chiedozie Nwagwu; Duc Minh Le; V Wee Yong; Hua Song; William T Couldwell
Journal:  J Neurosurg       Date:  2003-12       Impact factor: 5.115

9.  Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.

Authors:  Satoshi Nishizuka; Lu Charboneau; Lynn Young; Sylvia Major; William C Reinhold; Mark Waltham; Hosein Kouros-Mehr; Kimberly J Bussey; Jae K Lee; Virginia Espina; Peter J Munson; Emanuel Petricoin; Lance A Liotta; John N Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

10.  Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression.

Authors:  M Hsu; T Andl; G Li; J L Meinkoth; M Herlyn
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  9 in total

1.  Therapeutic implications of melanoma heterogeneity.

Authors:  Stephanie J Hachey; Alexander D Boiko
Journal:  Exp Dermatol       Date:  2016-05-19       Impact factor: 3.960

2.  Melanoma in patients with GATA2 deficiency.

Authors:  Jannett Nguyen; Tiffany Alexander; Hong Jiang; Natasha Hill; Zied Abdullaev; Svetlana D Pack; Amy P Hsu; Steven M Holland; Dennis D Hickstein; Eric A Engels; Isaac Brownell
Journal:  Pigment Cell Melanoma Res       Date:  2017-12-10       Impact factor: 4.693

3.  Personalized genomic disease risk of volunteers.

Authors:  Manuel L Gonzalez-Garay; Amy L McGuire; Stacey Pereira; C Thomas Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

4.  Nuclear transport of cancer extracellular vesicle-derived biomaterials through nuclear envelope invagination-associated late endosomes.

Authors:  Germana Rappa; Mark F Santos; Toni M Green; Jana Karbanová; Justin Hassler; Yongsheng Bai; Sanford H Barsky; Denis Corbeil; Aurelio Lorico
Journal:  Oncotarget       Date:  2017-02-28

5.  Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.

Authors:  Taku Sato; Tomoki Muramatsu; Minoru Tanabe; Johji Inazawa
Journal:  Cancer Sci       Date:  2018-09-21       Impact factor: 6.716

6.  Anti-human CD9 antibody Fab fragment impairs the internalization of extracellular vesicles and the nuclear transfer of their cargo proteins.

Authors:  Mark F Santos; Germana Rappa; Jana Karbanová; Cheryl Vanier; Chikao Morimoto; Denis Corbeil; Aurelio Lorico
Journal:  J Cell Mol Med       Date:  2019-04-13       Impact factor: 5.310

7.  Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation.

Authors:  Sandra Pinto; Alicia Martínez-Romero; José-Enrique O'Connor; Rosario Gil-Benso; Teresa San-Miguel; Liria Terrádez; Carlos Monteagudo; Robert C Callaghan
Journal:  BMC Cancer       Date:  2014-02-22       Impact factor: 4.430

8.  Comparative Genomic Analysis of the DUF34 Protein Family Suggests Role as a Metal Ion Chaperone or Insertase.

Authors:  Colbie J Reed; Geoffrey Hutinet; Valérie de Crécy-Lagard
Journal:  Biomolecules       Date:  2021-08-27

Review 9.  Membrane Transporters and Channels in Melanoma.

Authors:  Ines Böhme; Roland Schönherr; Jürgen Eberle; Anja Katrin Bosserhoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.